FN1 and cancer: The N-20 antibody reduced the adhesion of cancer cells to FN to ∼51% in Mahlavu cells, ∼60% in SMMC7721 cells as compared with control cells (P < 0.01, chi-squared test) (Figures 2(c) and 2(d)).